Predictions
PAVmed Inc
Start price
Target price
Perf. (%)
€1.41
20.03.22
20.03.22
-
20.03.23
20.03.23
-80.13%
21.03.23
21.03.23
Probably not worthwhile Investment
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€7.59
01.04.22
01.04.22
€12.50
01.04.23
01.04.23
-76.56%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
Euromedis Groupe
Start price
Target price
Perf. (%)
€10.64
24.12.21
24.12.21
-
24.12.22
24.12.22
-57.99%
25.12.22
25.12.22
Could be worthwhile Investment >10% per year
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€19.20
12.12.22
12.12.22
€0.000
12.12.23
12.12.23
-63.50%
15.12.22
15.12.22
Capable Management
Risky Investment
No uniques
No Innovation
Mauna Kea Tech
Start price
Target price
Perf. (%)
€0.84
07.11.21
07.11.21
€1.10
07.11.22
07.11.22
-33.61%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Euromedis Groupe
Start price
Target price
Perf. (%)
€4.10
04.10.22
04.10.22
-
04.10.23
04.10.23
14.15%
25.10.22
25.10.22
Probably not worthwhile Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.62
13.09.22
13.09.22
-
13.09.23
13.09.23
-37.10%
17.09.22
17.09.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.62
14.09.22
14.09.22
-
14.09.23
14.09.23
1.70%
17.09.22
17.09.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.91
13.08.22
13.08.22
€1.00
13.08.23
13.08.23
-12.70%
23.08.22
23.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.77
10.06.22
10.06.22
€0.20
10.06.23
10.06.23
24.58%
26.06.22
26.06.22
Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
PAVmed Inc
Start price
Target price
Perf. (%)
€1.35
21.03.22
21.03.22
€8.00
21.03.23
21.03.23
-14.92%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Vyant Bio Inc.
Start price
Target price
Perf. (%)
€8.50
30.03.22
30.03.22
-
30.03.23
30.03.23
-24.12%
31.03.22
31.03.22
Risky Investment
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.16
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-67.09%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€35.75
23.01.21
23.01.21
-
23.01.22
23.01.22
-73.67%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.00
17.01.22
17.01.22
-
17.01.23
17.01.23
-44.67%
22.01.22
22.01.22
Risky Investment
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€30.00
04.10.21
04.10.21
-
04.10.22
04.10.22
-39.47%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€52.08
13.08.21
13.08.21
€20.00
13.08.22
13.08.22
-65.13%
08.01.22
08.01.22
Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
Pixium Vision S.A.
Start price
Target price
Perf. (%)
€1.03
17.02.21
17.02.21
€3.00
17.02.22
17.02.22
-24.32%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
Euromedis Groupe
Start price
Target price
Perf. (%)
€22.15
12.04.21
12.04.21
€28.35
12.04.22
12.04.22
-51.96%
24.12.21
24.12.21
Could be worthwhile Investment >10% per year
Rewalk Robotics Ltd.
Start price
Target price
Perf. (%)
€1.19
05.10.21
05.10.21
-
05.10.22
05.10.22
41.25%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.90
22.09.20
22.09.20
-
04.11.21
04.11.21
-49.70%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€2.48
14.06.20
14.06.20
€5.00
04.11.21
04.11.21
-8.87%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model